Group One Trading’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Other funds holding KYMR
BBA
ACA
BI
AVLSA
SL
Group One Trading's KYMR Position: Q4 2022 in Review
Group One Trading sold out of Kymera Therapeutics (KYMR) in Q4 2022, closing a stake of 6,770 shares — an estimated $181K sold.
Group One Trading first reported a position in KYMR in Q1 2022 and held it in 2 quarters. The position peaked at $147K in Q3 2022. 121 funds tracked by Wall St. Rank hold KYMR as of Q4 2022.
- Group One Trading reported no remaining Kymera Therapeutics position as of Q4 2022 after selling out during the quarter.
- Group One Trading sold 6,770 Kymera Therapeutics shares in Q4 2022, an estimated $181K.
- Group One Trading first reported a position in Kymera Therapeutics in Q1 2022 and held it in 2 quarters.
- Group One Trading's Kymera Therapeutics position peaked at $147K in Q3 2022.
- 121 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q4 2022.
Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.